Title :

État des lieux des pratiques de prise en charge des cancers des voies biliaires en France : résultats de l'enquête nationale ACABi

Author(s) :

Delaye, Matthieu [Auteur correspondant]
Institut Curie - Saint Cloud [ICSC]
Assenat, Eric [Auteur]
Institut de Recherche en Cancérologie de Montpellier [IRCM - U1194 Inserm - UM]
Institut régional de Cancérologie de Montpellier [ICM]
Boleslawski, Emmanuel [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Camus, Marine [Auteur]
Centre de Recherche Saint-Antoine [CRSA]
Edeline, Julien [Auteur]
Oncogenesis, Stress, Signaling [OSS]
CRLCC Eugène Marquis [CRLCC]
Henriques, Julie [Auteur]
Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon]
Herrero, Astrid [Auteur]
Pôle Digestif [CHRU Montpellier]
Institut régional de Cancérologie de Montpellier [ICM]
Lièvre, Astrid [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Oncogenesis, Stress, Signaling [OSS]
Malka, David [Auteur]
Département de médecine oncologique [Gustave Roussy]
Institut Gustave Roussy [IGR]
Turpin, Anthony [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Vernerey, Dewi [Auteur]
Service d'Oncologie Médicale [CHRU Besançon]
Neuzillet, Cindy [Auteur]
Institut Curie - Saint Cloud [ICSC]

Journal title :

Bulletin du Cancer

Pages :

11S3-11S10

Publisher :

John Libbey Eurotext

Publication date :

2022-11

ISSN :

0007-4551

Keyword(s) :

Diagnostic moléculaire
Tumeurs des voies biliaires
Évaluation des pratiques

English keyword(s) :

Biliary tract cancers
CISGEM
Molecular profiling
Practice assessment

HAL domain(s) :

Sciences du Vivant [q-bio]/Cancer
Sciences du Vivant [q-bio]/Médecine humaine et pathologie/Hépatologie et Gastroentérologie

English abstract : [en]

Overview of biliary tract cancer management practices in France: results of the ACABi national survey INTRODUCTION: Biliary tract cancers (BTC) are rare. Their management has evolved in recent years. ACABi conducted a ...
Show more >Overview of biliary tract cancer management practices in France: results of the ACABi national survey INTRODUCTION: Biliary tract cancers (BTC) are rare. Their management has evolved in recent years. ACABi conducted a survey on the management practices of CVB in France. METHODS: A questionnaire was developed by a multidisciplinary team and distributed (June-July 2021) by the French digestive oncology societies. The data were analyzed according to the type of practice center (group A: university hospital or cancer comprehensive center, group B: general hospital or private hospital) RESULTS: 172 physicians (hepato-gastroenterologists: 58.0%, oncologists: 19.5% and surgeons: 18.3%), representing all French regions, responded. Access to echo-endoscopy and endoscopic retrograde cholangio-pancreatography was identical between the groups (> 80%), unlike cholangioscopy (group A: 82.9%, group B: 63.6%). In the adjuvant setting, capecitabine was proposed in the majority (> 65%). For non-operable tumors, the most commonly used first-line chemotherapy was cisplatin/gemcitabine (CISGEM, 66.3%). In 38.5% of cases, it was not performed in the day hospital and only 13.6% proposed a break after a fixed number of courses. The most commonly used second-line treatment was 5FU/oxaliplatin (FOLFOX, 52.3%). Molecular profiling was performed in more than half of the patients for 41.1% of respondents in group A and 18.8% in group B. DISCUSSION: This survey shows the application of therapeutic standards but also certain practices diverging from the recommendations as well as disparities between centers.Show less >

Language :

Français

Popular science :

Non

Collections :

• Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017

Source :

Harvested from HAL

Submission date :

2024-02-17T03:33:43Z